A new program to fight post-thoractoromy fatigue, and insights into how late-stage lung cancer patients perceive the advice to remain active.

Clinicians should pay more attention to the debilitating symptoms of adolescent fatigue, say commentators responding to a survey that shows prolonged fatigue may indicate severe depression or anxiety.

Intensified therapy including CNS prophylaxis proves promising for reducing or delaying side effects in malignant B-cell lymphoma.

Do patients with a left ventricular assist device (LVAD) have a worse sex life, afraid to damage it, or a better one, because they feel better? Either way, studies say, they should be encouraged to discuss the question.

Evidence that both email and alternative therapies may help patients with irritable bowel syndrome, beyond the effects of medication.

A population-based case control study leads to reason to believe that taking either a selective-serotonin reductase inhibitor (SSRI) or a non-selective monoamine reuptake inhibitor slightly increases the risks for autism among the offspring of pregnant women with a history of depression.

Experts offer an update on current research in hedgehog signaling pathway inhibition in basal cell carcinoma, including efficacy and toxicity results for vismodegib (Erivedge), the first oral medication to win FDA approval for metastatic BCC treatment.

Small, twice-daily doses of rivaroxaban may offer an effective strategy to reduce thrombotic events in patients following ST-elevation myocardial infarction (STEMI).

New guidelines from the American College of Gastroenterology point out the increasing prevalence of celiac disease, and the challenges in diagnosis and treatment.

Platinum-based chemotherapy may be the best bet for thwarting aggressive triple-negative breast cancer, according to a preliminary study.

Not only are mobile apps good at assessing schizophrenia, they may be more acceptable to patients. Future apps may broaden the use of mobile technology to sense mental status.

Co-infection with a respiratory virus was not associated with worse outcomes among patients infected during the H1N1 influenza A virus pandemic of 2009. Still, a population-based prospective study shows that non-influenza viruses can help to shape a flu outbreak.

Nonsmall-cell lung cancer (NSCLC) patients lived significantly longer after definitive radiation therapy if they continued to take beta-blockers during treatment, according to clinicians from M.D. Anderson Cancer Center in Houston.

More evidence that brain stimulation eases depression. Add it to sertraline, and both treatments are more effective. Studying brain responses to this kind of stimulation should also increase our knowledge and allow tailored treatment.

Genetic subtypes of disease don't explain why breast cancer is more aggressive among African-American than Caucasian women. But genotypes may explain differences in immunity to HER2.

Linagliptin achieves significant improvements in glycemic control in a pooled analysis of clinical trials. And a separate randomized trial shows that it can spare insulin and protect kidneys in patients with type 2 diabetes and severe renal insufficiency.

Early phase trials suggest a role for amrubicin, a third-generation anthracycline, in both small cell and nonsmall-cell lung cancer.

New alternatives to docetaxel (including cabozanitib and abiraterone) are hot on its heels for treatment of prostate cancer, and another drug has potential to address docetaxel resistance.

Research seems to back the food supplement and additive theories surrounding attention deficit hyperactivity disorder--with some caveats.

An hour of continuous EEG monitoring can identify seiaures among patients with spells and altered mental status. Spells just before EEG spell out a worse prognosis.